melatonin and sleep quality
- Conditions
- Endometriosis.Endometriosis
- Registration Number
- IRCT20171209037794N4
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
The eligibility of each included patients will be confirmed by the gynecologist. Subjects eligible for the study must meet all of the following criteria at randomization: •18- 45 years of age, who had complained of endometriosis with EACPP, and Sleep disturbances based on PSQI questionnaire (score = 5). •No history of surgical or medical treatments for infertility. •Not smoking, drinking alcohol, and addiction to substance. •Lack of systemic illness diseases, such as diabetes, blood pressure, seizures
•continuous use of sleeping pills, anticoagulants and anticonvulsants •women treated with antidepressants •use of stimulants or hypnotics or anti-anxiety medications •recent diagnosis of mood disorders or neuropsychiatric symptoms (within 8 weeks) •pregnancy or breastfeeding •known hypersensitivity to melatonin •If the patient does not want to continue to participation •Ongoing or previous pharmacologically treated depression or bipolar disorder •Work involving nightshifts
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality. Timepoint: Before and 2 months after intervention. Method of measurement: PSQI-19 questionnaire.
- Secondary Outcome Measures
Name Time Method Pelvic pain. Timepoint: Before and two months after the intervention. Method of measurement: VAS score.